Clinical trials & evidence

Breast Cancer Immunotherapy Has a New Problem: Who Gets the Second Checkpoint?

Avexitide Phase 3 trial cuts post-bariatric hypoglycemia events by 55%

Small-Cell Lung Cancer Gets an ADC Signal With Teeth

Progressive MS Still Needs Repair, Not Relapse Logic

Pregnancy Is Now an ADHD Care Gap

Myeloma Gets an Accelerated Approval. The Endpoint Is the Politics.

Parkinson’s Gets Fast Track, Not Fast Proof

Anxiety Gets a Psychedelic Trial, Not a Shortcut

AI Wants to Choose Pancreatic Chemo
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
